Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Batimastat is a broad spectrum inhibitor of matrix metalloproteinases (MMP), with IC50 values of 1-5 nM for all MMPs tested, including MMP-1, -2, -3, -7, -9, -13, and -14.1,2,3,4 It also potently inhibits TNFα-converting enzyme (IC50 = 14.9 nM).2 Because of its action on MMPs, batimastat has anti-proliferative, anti-invasive, and anti-metastatic actions that are relevant, in particular, to cancer.5 Batimastat less effectively inhibits the processing of the low affinity IgE receptor CD23 (IC50 = 100 nM).6
WARNING This product is not for human or veterinary use.
1. Selectivity of inhibition of matrix metalloproteases MMP-
2. A potent, selective inhibitor of matrix metalloproteinase-
3. Aryl ketones as novel replacements for the C-
4. Inhibition of membrane-
5. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview. Mutat. Res. 753(1), 7-23 (2013).
6. Selective inhibition of low affinity IgE receptor (CD23) processing. Bioorg. Med. Chem. Lett. 8(1), 29-34 (1998).